Federal Register #Docket No. DEA-1701

Quagen Pharmaceuticals LLC Application to Import Diphenoxylate (Schedule II)

This opportunity concerns Quagen Pharmaceuticals LLC's application to the Drug Enforcement Administration (DEA) for registration as an importer of a controlled substance. - Government Buyer: - Drug Enforcement Administration (DEA), Justice Department - OEMs and Vendors: - Quagen Pharmaceuticals LLC (applicant and sole vendor) - Products/Services Requested: - Diphenoxylate (Schedule II controlled substance) - DEA Drug Code: 9170 - Quantity: Not specified - Purpose: Importation for distribution to customers - Unique or Notable Requirements: - No authorization for other activities or for importing finished dosage forms for commercial sale - DEA approval contingent on compliance with federal regulations - Public comments, objections, or hearing requests are invited regarding this application - Place of Performance/Delivery: - 37 Fairfield Place, West Caldwell, New Jersey 07006 (Quagen Pharmaceuticals LLC location) - DEA as the contracting office

Description

Quagen Pharmaceuticals LLC has applied to be registered as an importer of basic classes of controlled substances, specifically Diphenoxylate (Schedule II). The company plans to import this controlled substance for distribution to its customers. The notice invites comments, objections, or requests for hearings on the application by May 18, 2026.

View original listing